ID   GNE-587170
AC   CVCL_AT69
SY   OCI-Ly-3 Boston variant
DR   BioSample; SAMN03470848
DR   Wikidata; Q54871608
RX   PubMed=25877200;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. This cell line was mistakenly distributed by OCI to a number of groups as being OCI-Ly-3 (Cellosaurus=CVCL_8800). The real identity of this cell line is not known. From personal communication of Neve, Richard M.
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00517.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,13
ST   D16S539: 10
ST   D18S51: 18,19
ST   D21S11: 28,30
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 21,25
ST   Penta D: 2.2,8
ST   Penta E: 5,8
ST   TH01: 7
ST   TPOX: 6,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Undefined cell line type
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 11
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu, Ma-Mie
RA   Selvaraj, Suresh K.
RA   Liang-Chu, May M.Y.
RA   Aghajani, Sahar
RA   Busse, Matthew
RA   Yuan, Jean
RA   Lee, Genee
RA   Peale, Franklin V.
RA   Klijn, Christiaan
RA   Bourgon, Richard
RA   Kaminker, Joshua S.
RA   Neve, Richard M.
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//